Concerns remain across the UK about cancer mortality rates compared with those in other countries, and a study on Wednesday warned that older people still faced "age-bias" in treatment for cancer.
Currently, percutaneous drainage is the first treatment of choice for hepatic abscesses because of its high success and low mortality rates compared with other surgical procedures.
The new paper, published in the prestigious US journal Jama Internal Medicine, says eating trans-fats and saturated fats, including those from red meat and butter, is linked to higher mortality rates compared with the same number of calories from carbohydrates.
A number of studies have reported that BRCA2 mutation carriers have more aggressive disease, suggested by their younger age at diagnosis, higher rates of lymph node involvement and distant metastasis at diagnosis, and higher mortality rates compared with non-carriers (Tryggvadóttir et al, 2007; Mitra et al, 2008; Edwards et al, 2010; Gallagher et al, 2010; Thorne et al, 2011; Castro et al, 2013).
Haemorrhage and hypertension have been the main causes of maternal death, while pulmonary embolism has had a minor affect on maternal mortality rates compared to other countries, particularly in Europe.
Heart failure in African Americans is characterized by a higher prevalence, especially at younger ages; more-adverse course with more frequent hospitalizations; and higher mortality rates compared to the general population.
This work built upon the phenomena of hidden heterogeneity and mortality selection, showing that current smokers who had survived to age 80 and beyond did not exhibit higher mortality rates compared to never-smokers of the same age (mortality had 'selected for' a resilient group).
Patients with delirium had higher hospital and SICU mortality rates compared with patients without delirium (Table 1).
Recent prospective and retrospective cohort studies have documented lower mortality rates compared with the mortality rates previously reported [16, 23, 29 33].
RESULTS: The highest-income beneficiaries received higher rates of evidence-based medical therapy and had lower adjusted 30-day and 1-year mortality rates compared with the middle-income beneficiaries (30-day relative risk, 0.89 [95% confidence interval, 0.85-0.94]; and 1-year relative risk, 0.92 [95% confidence interval, 0.88-0.97]).
They saw 24.8% lower mean annual opioid overdose mortality rates compared with states without medical marijuana allowances.
